1,332
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain

, , , , & ORCID Icon
Pages 337-344 | Received 28 Jul 2016, Accepted 28 Sep 2016, Published online: 18 Jan 2017

References

  • Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630–5.
  • Schindler C, Plumlee C. Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 2008;19:311–18.
  • Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002;8:945–54.
  • Yu CL, Meyer DJ, Campbell GS, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995;269:81–3.
  • Masciocchi D, Gelain A, Villa S, et al. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy. Future Med Chem 2011;3:567–97.
  • Keskin O, Gursoy A, Ma B, et al. Principles of protein-protein interactions: what are the preferred ways for proteins to interact? Chem Rev 2008;108:1225–44.
  • Wells JA, McClendon CL. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007;450:1001–9.
  • Masciocchi D, Villa S, Meneghetti F, et al. Synthesis, structure-activity relationships and stereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors. Med Chem Comm 2012;3:592–9.
  • Becker S, Groner B, Muller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998;394:145–51.
  • Zhao M, Jiang B, Gao FH. Small molecule inhibitors of STAT3 for cancer therapy. Curr Med Chem 2011;18:4012–18.
  • Mankan AK, Greten FR. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors. Expert Opin Investig Drugs 2011;20:1263–75.
  • Siddiquee K, Zhang S, Guida WC, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007;104:7391–6.
  • Fletcher S, Singh J, Zhang X, et al. Disruption of transcriptionally active Stat3 dimers with nonphosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities. Chem Bio Chem 2009;10:1959–64.
  • Zhang X, Yue P, Page BD, et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci USA 2012;109:9623–8.
  • Urlam MK, Pireddu R, Ge Y, et al. Development of new N-arylbenzamides as STAT3 dimerization inhibitors. Medchemcomm 2013;4:932–41.
  • Reddy BS, Kawamori T, Lubet R, et al. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Carcinogenesis 1999;20:1645.
  • Perrino E, Cappelletti G, Tazzari V, et al. New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity. Bioorg Med Chem Lett 2008;18:1893–7.
  • Wedel SA, Sparatore A, Del Soldato P, et al. New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma. J Cell Mol Med 2008;12:2457–66.
  • Tesei A, Brigliadori G, Carloni S, et al. Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity. J Cell Physiol 2012;227:3389–96.
  • Uehara Y, Mochizuki M, Matsuno K, et al. Novel high-throughput screening system for identifying STAT3-SH2 antagonists. Biochem Biophys Res Commun 2009;380:627–31.
  • Tian Y, Ye Y, Gao W, et al. Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway. Int J Colorectal Dis 2011;26:13–22.
  • Kim SR, Bae MK, Kim JY, et al. Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells. Biochem Biophys Res Commun 2009;387:342–7.
  • Nikitakis NG, Hamburger AW, Sauk JJ. The nonsteroidal anti-inflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells. Cancer Res 2002;62:1004–7.
  • Frantias J, Logan JG, Mollat P, et al. Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. British J Pharm 2012;165:1914–25.
  • Foong LY, You S, Jaikaran DC, et al. Development of a novel thiol reagent for probing ion channel structure: studies in a model system. Biochemistry 1997;36:1343.
  • Sparatore A, Del Soldato P. Sulindac derivatives for treatment of cancer. WO 2006134489; 2006.
  • Del Soldato P, Santus G, Sparatore A. Thiosulfonate anti-inflammatory agents. WO2007101606(A1); 2007.
  • Boldyrev BG, Grivnak LM, Kolesnikova SA, et al. Thiosulfonic acids XV β-chloroethyl, β-hydroxy-ethyl, and carboxymethyl esters of thiosulfonic acids. Zhurnal Organicheskoi Khimii 1967;3:37–40.
  • Wang L, Clive Derrick LJ. Reagent for divalent sulfur protection: preparation of 4-methylbenzenesulfonothioic acid, S-[[[(1,1-dimethylethyl)-dimethylsilyl]oxy]methyl] ester. Organ Synth 2013;90:10–24.
  • Harte AJ, Gunnlaugsson T. Synthesis of α-chloroamides in water. Tetrahedron Lett 2006;47:6321–4.
  • Sheldrick GM. SADABS area-detector absorption correction program. Madison (WI): Bruker AXS Inc.; 2000.
  • Altomare A, Burla MC, Camalli M, et al. SIR97: a new tool for crystal structure determination and refinement. J Appl Cryst 1999;32:115–19.
  • Sheldrick GM. A short history of SHELX-97. Acta Crystallogr A 2008;64:112–22.
  • Farrugia LJ. Win GX. Suite for small-molecule single-crystal crystallography. J Appl Cryst 1999;32:837–8.
  • Ferri N, Cazzaniga S, Mazzarella L, et al. Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatin. Bioorg Med Chem 2013;21:2379–86.
  • Boldyrev BG, Vid LV, Khovalko LM, et al. Synthesis, structure, and properties of thiosulfonate esters bearing substituents in the ester group. Khim Seraorg Soedin, Soderzh Neftyakh Nefteprod 1972;9:282–6.
  • Verdine GL, Meena M, Iwanoto N, et al. Methods for the synthesis of functionalized nucleic acids. WO2013012758(A1); 2013.
  • Fan LC, Teng HW, Shiau CW, et al. Pharmacological targeting SHP-1-STAT3 signaling is a promising therapeutic approach for the treatment of colorectal cancer. Neoplasia 2015;17:687–96.
  • Akabas M, Stauffer D, Xu M, et al. Acetylcholine receptor channel structure probed in cysteine-substitution mutants. Science 1992;258:307–10.
  • Akabas MH, Kaufmann C, Archdeacon P, et al. Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit. Neuron 1994;13:919–27.
  • Akabas MH, Karlin A. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the alpha-subunit. Biochemistry 1995;34:12496–500.
  • Chen JG, Liu-Chen S, Rudnick G. External cysteine residues in the serotonin transporter. Biochemistry 1997;36:1479–86.